Navigation Links
Launch of New, Prestigious Infertility and Gynaecology Research GrAnt (FRIGGA)
Date:2/13/2008

PARSIPPANY, N.J., Feb. 13 /PRNewswire/ -- Ferring Pharmaceuticals has launched the first Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) for fundamental fertility and gynaecology research. This is an international, themed, biennial initiative open to individual researchers or research units/departments with the first awarded research projects to be completed by January 2010.

Professor Paul Devroey, Free University Brussels, will lead the international expert judging panel for FRIGGA. Two grants to the value of euros 50,000 each will be awarded with the announcement of first recipients of the awards at the European Society of Human Reproduction and Embryology (ESHRE) congress in Barcelona (6 - 9 July 2008). The deadline for the submission of grant applications is 30 April 2008.

The award is named after Frigga, the goddess of fertility, motherhood, love, family and home from Scandinavian mythology. This name encapsulates both the objective of infertility research and treatment -- parenthood -- and echoes the company's Scandinavian roots. The theme for the 2008 award is fundamental research leading to an increased understanding of the role of human chorionic gonadotrophin (hCG) in assisted reproduction.

Mr. Michel Pettigrew, Chief Operating Officer at Ferring said, "We are committed to taking the lead in the field of assisted reproductive technologies (ART) and the launch of FRIGGA reflects this commitment. We look forward to innovative research carried out through the FRIGGA award that will increase our understanding of infertility and that in the future will help infertile couples around the world achieve their goal."

In announcing the theme of the 2008 award, Paul Devroey, comments "We have made great progress in the treatment of infertility in what is quite a short period of time for medicine. If, however, we are to meet the growing needs for treatment and the growing expectation of treatment standards, we need to progress much further. Further research is key to this progress. We know, for example, that hCG has great importance in the fertility process, but the exact role of this hormone still remains a mystery. The theme we have selected for the 2008 award is, therefore, fundamental research leading to an increased understanding of the role of human chorionic gonadotrophin (hCG) in assisted reproduction. I would like to thank Ferring for their commitment to the infertility field of medicine and for establishing the FRIGGA grant for research."

For more information and a downloadable application form, please visit: http://www.Ferringresearchgrant.com.

About Ferring Pharmaceuticals

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of fertility, obstetrics, urology, gastroenterology and endocrinology. Ferring's fertility portfolio of treatments gives infertile couples the chance to have babies and includes its flagship brand MENOPUR(R), a recognised high quality treatment for infertility. Ferring has operating subsidiaries in over 40 countries. To learn more about Ferring or our products please visit http://www.ferring.com.


'/>"/>
SOURCE Ferring Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
3. BioSpace and BayBio Launch 11th Edition of Biotech Bay(TM) Hotbed Map Campaign
4. Novozymes Launches Enzyme to Reduce Acrylamide in Food
5. Enova Medical Launches Exos Corporation
6. Nitec Pharma AG Announces Appointments of CEO & CFO in Preparation for Launch of Lodotra(R)
7. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
8. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
9. Concuity Announces the Launch of Its New Fully Accessible Website - Concuity.Com
10. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
11. Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading software as ... Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and video ... trial team. , Using the CONSULT module, patients and physicians can schedule a face ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
Breaking Biology Technology:
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):